Advertisement
Advertisement

ARCT

ARCT logo

Arcturus Therapeutics Holdings Inc. Common Stock

9.22
USD
Sponsored
+0.32
+3.60%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

9.13

-0.09
-0.92%

Arcturus Therapeutics Holdings Inc. Common Stock Profile

About

Arcturus Therapeutics Ltd. is a preclinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of RNA medicines using proprietary lipid-mediated delivery system LUNAR(TM) and UNA Oligomer chemistry technologies. Arcturus Therapeutics Ltd, formerly known as Alcobra Ltd, is based in San Diego, CA.

Info & Links

CEO

Joseph E. Payne

Headquarters

10285 SCIENCE CENTER DRIVE
SAN DIEGO, CA 92121, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.arcturusrx.com

Auditor

Deloitte & Touche LLP

Share holders

8

Employees

111

Arcturus Therapeutics Holdings Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

259.64M

Enterprise Value

48.27M

Enterprise Value/EBITDA(ttm)

-0.56

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

2.85

Price to Book(mrq)

1.09

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-80.19%

Profit Margin(ttm)

-140.70%

Return on Equity(ttm)

-29.13%

Return on Invested Capital(ttm)

-29.21%

Return on Assets(ttm)

-22.03%

Income Statement

Revenue(ttm)

54.71M

Revenue Per Share(ttm)

--

Gross Profit(ttm)

54.71M

EBITDA(ttm)3

-85.48M

Net Income Available to Common(ttm)

-78.67M

Diluted EPS(ttm)

-2.38

Share Statistics

Beta (5Y Monthly)

2.44

52-Week Change

-18.98%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

23.70M

% Held by Insiders

16.60%

% Held by Institutions

94.54%

Balance Sheet

Total Cash(mrq)

211.38M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

6.64%

Quick Ratio(mrq)

6.64%

Book Value Per Share(mrq)

7.53

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.71

Free Cash Flow(ytd)

-74.50M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement